Gary Bellinger
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 5%
- Metabolism, Diabetes, and Cancer
- Redox biology and oxidative stress
- PI3K/AKT/mTOR signaling in cancer
- Mitochondrial Function and Pathology
- Protein Kinase Regulation and GTPase Signaling
Papers in
-
- Cancer, Hypoxia, and Metabolism 7
- Oncology 6
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Lewis C. Cantley (8 shared papers)John M. Asara (5 shared papers)George Poulogiannis (4 shared papers)Matthew G. Vander Heiden (3 shared papers)Atsuo T. Sasaki (3 shared papers)Jason W. Locasale (2 shared papers)Dimitrios Anastasiou (2 shared papers)Matthew B. Boxer (2 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Molecular Cell (2 papers)Cancer Research (2 papers)Cell (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Gary Bellinger
17 papers receiving 2.9k citations
Gary Bellinger's Hit Papers
Peers
Comparison fields: 5 of 94
- Cancer Research 1.2k
- Molecular Biology 1.3k
- Oncology 299
- Biochemistry 61
- Cell Biology 106
Countries citing papers authored by Gary Bellinger
This map shows the geographic impact of Gary Bellinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Bellinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Bellinger more than expected).
Fields of papers citing papers by Gary Bellinger
This network shows the impact of papers produced by Gary Bellinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Bellinger. The network helps show where Gary Bellinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Bellinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses Hit paper breakdown → | 2011 | 1030 |
| 2 | AMPK-Dependent Degradation of TXNIP upon Energy Stress Leads to Enhanced Glucose Uptake via GLUT1 Hit paper breakdown → | 2013 | 557 |
| 3 | 2013 | 449 | |
| 4 | 2014 | 215 | |
| 5 | 2013 | 180 | |
| 6 | 2013 | 165 | |
| 7 | 2016 | 80 | |
| 8 | 2004 | 71 | |
| 9 | 2013 | 59 | |
| 10 | 2017 | 47 | |
| 11 | 2008 | 45 | |
| 12 | 2006 | 20 | |
| 13 | 2022 | 17 | |
| 14 | 2016 | 15 | |
| 15 | 2017 | 13 | |
| 16 | Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses | 2011 | 3 |
| 17 | Identification of CDCP1 as a hypoxia-inducible factor 2 (HIF-2 ) target gene that is associated with survival in clear cell renal cell carcinoma patients | 2013 | 1 |
About Gary Bellinger
Gary Bellinger is a scholar working on Cancer Research, Oncology, Molecular Biology, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), HER2/EGFR in Cancer Research (3 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Head and Neck Cancer Studies (2 papers), Redox biology and oxidative stress (2 papers), Metabolism, Diabetes, and Cancer (2 papers), Cancer-related Molecular Pathways (2 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Cancer Research (1.2k citations), Molecular Biology (1.3k citations), Oncology (299 citations), Biochemistry (61 citations) and Cell Biology (106 citations). Gary Bellinger has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Lewis C. Cantley, John M. Asara, George Poulogiannis, Matthew G. Vander Heiden, Atsuo T. Sasaki, Jason W. Locasale, Dimitrios Anastasiou, Matthew B. Boxer, Craig J. Thomas and Min Shen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Molecular Cell, Cancer Research, Cell and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.